Vincristine and Vinblastine belong to:
Catharanthus roseus produces complex dimeric alkaloids via coupling of vindoline derived from tabersonine and catharanthine moieties through peroxidase α-3′,4′-anhydrovinblastine synthase. Resulting vinblastine and vincristine contain indole and dihydroindole units fused through intricate polycyclic framework bearing basic nitrogen essential for biological activity. They disrupt mitosis by specifically binding at vinca site on β-tubulin, preventing microtubule polymerization, arresting cells at metaphase, and inducing apoptosis through JNK pathway. Clinical importance in chemotherapy of childhood leukemia and lymphomas reflects high potency. Alkaloid definition includes heterocyclic nitrogen, basic nature, derivation from amino acid tryptophan via strictosidine intermediate, and pharmacological activity. Therefore vincristine and vinblastine exemplify terpenoid indole alkaloids, distinguishing them from flavonoids, terpenoids without nitrogen, or simple phenolics, and underpinning their status as high-value pharmaceutical secondary metabolites. Pathway involves strictosidine synthase condensing tryptamine and secologanin, then multiple enzymatic steps generating monomeric precursors. Dimerization via α-3′,4′-anhydrovinblastine synthase produces vinblastine which may be converted to vincristine by oxidation. Clinical formulation requires extensive purification from leaf biomass. Classification as alkaloid due to nitrogen heterocycles and basic nature distinguishes them from neutral terpenoids, highlighting medicinal importance of secondary metabolite diversity.
Ref: van Der Heijden Curr Med Chem 2004 Catharanthus alkaloids; NCBI NBK21154 indole alkaloid; Cragg Nat Prod Vinca; PubMed 15075446.